BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17053080)

  • 1. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.
    Spera JM; Ugalde JE; Mucci J; Comerci DJ; Ugalde RA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16514-9. PubMed ID: 17053080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella alters the immune response in a prpA-dependent manner.
    Spera JM; Comerci DJ; Ugalde JE
    Microb Pathog; 2014; 67-68():8-13. PubMed ID: 24508400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Brucella virulence factor targets macrophages to trigger B-cell proliferation.
    Spera JM; Herrmann CK; Roset MS; Comerci DJ; Ugalde JE
    J Biol Chem; 2013 Jul; 288(28):20208-16. PubMed ID: 23720774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Brucella abortus virulence proteins that modulate the host immune response.
    Wang Y; Chen Z; Qiu Y; Ke Y; Xu J; Yuan X; Li X; Fu S; Cui M; Xie Y; Du X; Wang Z; Huang L
    Bioengineered; 2012; 3(5):303-5. PubMed ID: 22743689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a Brucella abortus lipoprotein in intracellular replication and pathogenicity in experimentally infected mice.
    Kim DH; Son BG; Lim JJ; Lee JJ; Kim DG; Lee HJ; Min W; Rhee MH; Kim KD; Chang HH; Kim S
    Microb Pathog; 2013 Jan; 54():34-9. PubMed ID: 23006628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.
    Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC
    Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response of TLR4 deficient spleen macrophages (CRL 2471) to Brucella abortus S19 and an isogenic ΔmglA deletion mutant.
    Jacob J; Makou P; Finke A; Mielke M
    Int J Med Microbiol; 2016 May; 306(3):141-51. PubMed ID: 26946956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Brucella abortus sigma factor sigma54 (rpoN): genetic complementation of Sinorhizobium meliloti ntrA mutant.
    Iannino F; Ugalde RA; Iñón de Iannino N
    Microb Pathog; 2008; 45(5-6):394-402. PubMed ID: 18926896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-profiles of BALB/c mice inoculated with Salmonella vector delivering B-cell mitogen hydroxyproline epimerase.
    Lalsiamthara J; Lee JH
    Mol Immunol; 2018 Mar; 95():114-121. PubMed ID: 29433066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in the pathogenicity of Brucella abortus infection in vitro and in vivo.
    Canavessi AM; Harms J; de Leon Gatti N; Splitter GA
    Microb Pathog; 2004 Nov; 37(5):241-51. PubMed ID: 15519045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host.
    Hoffmann EM; Houle JJ
    Crit Rev Microbiol; 1995; 21(3):153-63. PubMed ID: 8845060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium.
    Sangari FJ; Seoane A; Rodríguez MC; Agüero J; García Lobo JM
    Infect Immun; 2007 Feb; 75(2):774-80. PubMed ID: 17101645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella abortus synthesizes phosphatidylcholine from choline provided by the host.
    Comerci DJ; Altabe S; de Mendoza D; Ugalde RA
    J Bacteriol; 2006 Mar; 188(5):1929-34. PubMed ID: 16484204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ferrous iron transporter FtrABCD is required for the virulence of Brucella abortus 2308 in mice.
    Elhassanny AE; Anderson ES; Menscher EA; Roop RM
    Mol Microbiol; 2013 Jun; 88(6):1070-82. PubMed ID: 23647104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brucella abortus efp gene is required for an efficient internalization in HeLa cells.
    Iannino F; Ugalde JE; Iñón de Iannino N
    Microb Pathog; 2012 Jan; 52(1):31-40. PubMed ID: 21983596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of natural killer (NK) cells on antibody responses to Brucella abortus.
    Gao N; Jennings P; Guo Y; Yuan D
    Innate Immun; 2011 Apr; 17(2):152-63. PubMed ID: 20418255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.